NEK2 and neoplasm: We observed that either single knockdown of Nek2 or sorafenib treatment could inhibit tumor growth; however, the combination of Nek2 knockdown and sorafenib treatment resulted in the most significant inhibition of tumor growth (Fig. 5a, b).